Navigation Links
Biolytix to Offer Industrial Gene Expression Analysis and Genotyping Services Using Affymetrix' GeneChip(R) Technology
Date:11/29/2007

WITTERSWIL, Switzerland, November 29 /PRNewswire/ -- Biolytix AG (http://www.biolytix.ch) signed a service provider agreement with Affymetrix UK Ltd (http://www.affymetrix.com) and offers genomic analysis services for the academic and industrial R&D community under conditions compliant with a stringent quality management system.

Biolytix, one of the leading CRO's for molecular biological analysis in Switzerland has acquired a complete Affymetrix GeneChip(R) instrument system to enhance the range of services offered. Besides standard gene expression analysis services, with this state-of-the-art equipment Biolytix is ready to offer services using the latest generation GeneChip(R) products. These include Exon and Tiling arrays as well as SNP genotyping and gene mapping arrays with potential applications in transcriptome mapping, the analysis of gene regulation as well as genome wide SNP mapping and re-sequencing using standard and custom arrays.

The appointment of Biolytix as an Affymetrix authorized service provider further enhances the strong reputation of the company in the molecular biology service provider community. Current and future customers of Biolytix worldwide have now access to the offerings of Affymetrix via the services provided by the company.

Biolytix AG, specialized in molecular and microbiological analyses, was founded in 1998 and is situated in Witterswil (Switzerland), 12 km south-west of Basel. The team and its scope of activities have been expanding continuously. Biolytix, accredited according to ISO/IEC 17025, offers a wide range of services, the major ambition being to fulfil the customers' expectations through confidential and responsible cooperation. The fields of activity of Biolytix are widely distributed in the pharmaceutical, food and cosmetic industry as well as in the veterinarian, agricultural and human diagnostics.

For further information please contact:

Adrian Harri, CEO,

adrian.haerri@biolytix.ch,

Biolytix AG,

Benkenstrasse 254,

CH-4108 Witterswil,

Switzerland,

Tel. +41(0)61-7252070,

Fax. +41(0)61-7252071


'/>"/>
SOURCE Biolytix AG
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Health care incentive model offers collaborative approach
3. Eye-staining technique offers early detection for dry eye syndrome
4. Governor Rendell Offers adultBasic Coverage to 35,000 Uninsured Pennsylvanians
5. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
6. Psoriasis Cure Now offers Back to School Resources for Parents of Children with Psoriasis
7. ADDAS Awareness Campaign Offers Resources and Education to Adults Living with AD/HD and Professionals Working With Them
8. Consumers Offer to Pay More to Satisfy Health Demands
9. Regence Offers InterM to Fill Gap for the Uninsured
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Super Jake Foundation Offers Hope for Pediatric Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... addition of predictive analytics to its patient care management module. Using this new ... before a patient has been initiated on continuous positive airway pressure (CPAP), oral, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
(Date:4/24/2017)... ... 2017 , ... Ridgecrest Herbals makes it a point to lead the Utah ... and support renewable energy. They believe this is a crucial part of their mission ... health issues, and maintain that destroying the environment in the pursuit of profit is ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology: